Repligen Corporation Profile Avatar - Palmy Investing

Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding com…

Medical - Instruments & Supplies
US, Waltham [HQ]

Balance Sheet

14 Sheets · Starting from 2010
In Million USD. Margins, Growth Rates In %
Metric 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
71.00 72.00 97.00 118.00 -65.00 146.00 288.00 120.00 139.00 1,400.00 1,902.00 2,358.00 2,524.00 2,824.00
Current
59.00 55.00 66.00 86.00 80.00 103.00 184.00 242.00 275.00 641.00 902.00 931.00 998.00 1,111.00
Non Current
11.00 16.00 30.00 32.00 47.00 42.00 104.00 500.00 498.00 758.00 1,000.00 1,426.00 1,526.00 1,713.00
Liabilities
5.00 5.00 12.00 14.00 15.00 23.00 120.00 151.00 155.00 340.00 373.00 608.00 613.00 853.00
Current
4.00 4.00 10.00 11.00 10.00 18.00 21.00 25.00 129.00 48.00 318.00 375.00 404.00 158.00
Non Current
- - - - 2.00 3.00 5.00 4.00 99.00 126.00 29.00 292.00 54.00 233.00 209.00 695.00
Equity
66.00 67.00 84.00 103.00 -80.00 122.00 -59.00 -31.00 -15.00 5.00 65.00 1,750.00 397.00 1,971.00
Stockholders' Equity
66.00 67.00 84.00 103.00 -80.00 122.00 -59.00 -31.00 -15.00 5.00 65.00 1,750.00 397.00 1,971.00
Retained Earnings
-117.00 -117.00 -105.00 -89.00 -80.00 -71.00 -59.00 -31.00 -15.00 5.00 65.00 194.00 397.00 438.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
-4.00 - - 14.00 16.00 8.00 9.00 11.00 28.00 16.00 21.00 59.00 128.00 185.00 41.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
189.00 191.00 187.00 190.00 198.00 202.00 242.00 628.00 11.00 14.00 -2.00 1,572.00 33.00 1,569.00
Loss Other Compr. Income
-5.00 -6.00 1.00 1.00 -5.00 -8.00 -13.00 -6.00 -11.00 -15.00 2.00 -16.00 -34.00 -37.00
End of RGEN's Analysis
CIK: 730272 CUSIP: 759916109 ISIN: US7599161095 LEI: - UEI: -
Secondary Listings
RGEN has no secondary listings inside our databases.